https://www.newswire.ca/news-releases/gsk-canada-submits-respiratory-syncytial-virus-rsv-vaccine-candidate-for-regulatory-review-856610570.html
0
0
11/26/22 at 12:10am
Organization
Canada NewsWire
40 words
0
Comments
/CNW/ - GSK has filed a New Drug Submission (NDS) to Health Canada for its respiratory syncytial virus (RSV) older adult vaccine candidate. If approved, GSK's...
You are the first to view
Create an account
or login to join the discussion